TECHNOLOGIES

Next-Generation LNP R&D and Manufacturing Architecture

Precision Nanoengineering

Hermez Nanomedicine is advancing the frontier of lipid nanoparticle (LNP) technology through precision 30–50 nm nanoengineering and a proprietary one-pot synthesis system. Our unified framework bridges the gap from molecular design to industrial-scale manufacturing, empowering partners to overcome biological barriers with clinical efficiency and stability.

Precision Nanoengineering

Hermez Nanomedicine is advancing the frontier of lipid nanoparticle (LNP) technology through precision 30–50 nm nanoengineering and a proprietary one-pot synthesis system. Our unified framework bridges the gap from molecular design to industrial-scale manufacturing, empowering partners to overcome biological barriers with clinical efficiency and stability.

Precision Nanoarchitecture
(30–50 nm)

Hermez’s core competitiveness lies in the ultimate control over the physicochemical properties of nanoparticles.

icon-pn-01

Size Distribution Control

We have established a proprietary design framework capable of strictly stabilizing LNP size within the 30–50 nm range.

icon-pn-02

Optimized Biodynamics

This specific nanoarchitecture is engineered to maximize tissue penetration, optimize circulation dynamics, and enhance cellular uptake efficiency.

icon-pn-03

Enhanced Safety Profile

Through precision control, we effectively minimize off-target distribution, thereby reducing the risk of systemic toxicity.

icon-pn-04

High Customizability

Our platform supports programmable lipid compositions, molar ratio optimization, and surface functionalization strategies for tissue-selective targeting.

Proprietary One-Pot Synthesis System

We believe that scientific innovation must be translated into manufacturing precision. To achieve this, we developed an exclusive One-Pot manufacturing process.

icon-pn-05

Integrated Single-Step Process

Complex nanoparticle assembly is integrated into a controlled, single-step architecture, significantly reducing process complexity.

icon-pn-06

Ultimate Consistency

This technology ensures high reproducibility in nanoparticle formation and achieves rigorous batch-to-batch consistency.

icon-pn-07

High-Efficiency Production Cycle

The complete production cycle can be executed within 24 hours, maximizing the efficiency of R&D and clinical supply timelines.

Clinical Translation and Scalability Advantage

The Hermez platform is more than an R&D tool; it is an industrial system ready for commercialization.

icon-pn-08

Seamless Scale-Up

Our process architecture is engineered to support a seamless transition from 100 mL laboratory development batches to 500 L industrial-scale production.

icon-pn-09

Functional Integrity Assurance

We ensure that particle structural integrity and functional performance remain uncompromised during the scale-up process.

icon-pn-10

Comprehensive R&D Support

By integrating nanoengineering, pharmacokinetic modeling, scalable CMC (Chemistry, Manufacturing, and Controls) strategies, and regulatory alignment, we effectively de-risk drug programs for our partners.